Cervical Cytology - Do SMS Reminders Increase Participation in the Cervical Screening Programme?

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50000 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-12-01

Study Completion Date

2021-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will pilot production and evaluate the use of reminder information in women invited for cervical screening for the first time within the GGC eligible population for cervical screening. Women aged under 30 years will be identified to receive an SMS text message following their cervical screening invitation using information from the CHI Broadcast.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Can Text Reminders Improve Uptake of Cervical Screening?

NCT02363088

Cervical Carcinoma Cervical Dysplasia

COMPLETED NA

Increasing Cervical Cancer Screening Uptake Among Emergency Department Patients

NCT04374760

Cervical Cancer

COMPLETED NA

An Observational Study of GP Verbal Reminders Upon Cervical Screening

NCT04970394

COMPLETED

SMS Messaging for Invitation in the Cervical Cancer Screening Programme

NCT05362669

Cervical Cancer Human Papilloma Virus

UNKNOWN NA

Promoting Cervical Cancer Screening for Emergency Department Patients

NCT03483610

Cervical Cancer

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Cervical cancer is the commonest cancer among women aged less than 35 years. A change to the age range and frequency for cervical screening was implemented on the 6th June 2016. This increased the younger eligible age for screening from 20 to 25. Uptake of cervical screening among women in the youngest eligible age range has historically been low. Research by Scott Porter has shown that cervical screening is not on young women's radar and additionally there is scope for confusion amongst women in this cohort about the requirement to attend for cervical screening if they have been previously immunised against HPV (human papilloma virus) generally in secondary school in year 2, some 12 years earlier.

The HPV vaccine was introduced in 2008 and is designed to protect against the two types of high risk HPV which cause approximately 75% of all cervical cancer. Advice to all eligible women who have been vaccinated remains that participation in cervical screening is necessary to provide the most comprehensive protection against cervical cancer, as the current vaccine does not provide protection against all high risk cancer causing strains of HPV.

Research from other screening programmes has also shown that where individuals engage with a screening programme from the start, they are more likely to continue to participate in screening for as long as they are eligible.

"Intending to, but not getting round to it", is the reason most associated with non-response to cervical cancer screening invitations.

GGC serves approximately 40% of the total Scottish population and therefore testing the reminder in the GGC population provides an opportunity to compare the impact of the SMS text reminder in this cohort with management as usual within the remainder of the Scottish eligible population. This should enable us to identify whether use of a reminder SMS text message is in fact likely to add value and increase participation in cervical screening.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Carcinoma Cervical Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

The study arms are as follow:

1. No intervention: women will routinely be invited to attend for cervical screening via the SCCRS application.
2. Experimental: Women aged under 30 years will be identified to receive an SMS following cervical screening invitation using information from the CHI Broadcast

Primary Study Purpose

SCREENING

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Routine

women will routinely be invited to attend for cervical screening via the SCCRS application.

Group Type NO_INTERVENTION

No interventions assigned to this group

SMS

Women aged under 30 years will be identified to receive an SMS following cervical screening invitation using information from the CHI Broadcast

Group Type EXPERIMENTAL

SMS text

Intervention Type OTHER

A single SMS text sent to women under 30 who are eligible for the cervical screening programme and who have been invited by letter

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SMS text

A single SMS text sent to women under 30 who are eligible for the cervical screening programme and who have been invited by letter

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All women aged under 30 years who are eligible for cervical screening with a CHI number and registered with a GP in the NHS Greater Glasgow and Clyde area.